Login to Your Account

Week in Review

Monday, December 5, 2011


ArGen-X BV raised $37.1 million in a Series B round.

Celsion Corp. is raising $15 million in a private placement of stock and warrants.

Inhibitex Inc. raised $20 million through an at-the-market offering.

NuCana BioMed Ltd. raised $10.5 million in a Series A round for anticancer nucleoside analogues.

Oxigene Inc. established a $20 million standby equity purchase agreement.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription